SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant market volatility driven by a disappointing first-quarter delivery report that missed analyst expectations, fueling intense community debate regarding the company's core automotive demand versus its long-term AI and robotics narrative. While some investors view the stock's weakness as a prime opportunity to buy the dip, others are aggressively betting against the position, citing concerns over declining sales, global competition, and the potential distraction of the anticipated SpaceX IPO.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

Kelly Services is experiencing intense volatility driven by its extremely low float and active accumulation by institutional players and insiders, which has fueled widespread community speculation about a potential short squeeze. Traders are closely monitoring upcoming earnings and corporate conference calls as potential catalysts for further upward movement.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space (FJET) is experiencing heightened trading activity fueled by speculative interest in the broader space sector, specifically anticipation surrounding a potential SpaceX IPO and the company's recent operational updates at the Midland Air & Space Port. The stock remains a major talking point among retail investors, who are actively debating the company's long-term viability versus the potential for a volatile short squeeze given its small float and high short interest.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing heavy volatility as traders debate the sustainability of its parabolic rally following its S&P 500 inclusion and massive AI-driven infrastructure demand. The community is sharply divided between bulls citing mission-critical optical networking bottlenecks and bears warning of a potential liquidity trap or bubble valuation.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing heightened investor attention as recent high-profile partnerships at CESspecifically with automotive leaders like BMW and the strategic collaboration with Vector Informatik on the Alloy Kore platformreignite discussions about the company's expanding role in the software-defined vehicle market. The community is actively debating the potential for increased average revenue per unit through these higher-value software integrations, even as some participants remain skeptical about management's ability to translate technical milestones into consistent, long-term revenue growth.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The SPY is currently trading in a highly volatile, news-driven environment where investors are attempting to reconcile a significant spike in oil prices with a resilient equity market. Market participants remain deeply divided and cautious, with heavy debate focusing on whether the current price action is a genuine reversal or a manipulative bull trap designed to liquidate option premiums ahead of the long holiday weekend.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is experiencing intense volatility driven by conflicting signals between rising oil prices and algorithmic buying, leading to significant friction between bearish sentiment over geopolitical instability and bullish institutional accumulation. Community discussion is dominated by intense frustration over market manipulation, with retail traders debating whether the rapid price swings represent a sustainable rally or a deceptive trap ahead of the upcoming holiday weekend.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is surging as traders react to heightened geopolitical tensions in the Middle East following official comments that military operations in Iran will continue, fueling fears of sustained energy supply disruptions. The community is heavily focused on the potential for a prolonged conflict and its inflationary impact, with active debates centered on whether oil prices are entering a long-term structural uptrend or if the current market action is a temporary headline-driven squeeze.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors monitor the early commercial launch of its FDA-approved therapy YARTEMLEA and await updates on potential milestone payments from its partnership with Novo Nordisk. Community discussion is heavily focused on the stock's undervaluation relative to its pipeline potential, the impact of significant short interest, and optimism surrounding upcoming European regulatory decisions.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors react to a revenue beat in its recent earnings report while balancing anticipation for potential U.S. federal cannabis rescheduling news. The community is actively debating the company's long-term pivot toward a broader consumer packaged goods strategy, with vocal arguments contrasting management's performance against the broader sector's volatility and policy-driven outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zai Lab (NASDAQ:ZLAB) Trading 9.5% Higher - Still a Buy?

Zai Lab (NASDAQ:ZLAB) Trading Up 9.5% - What's Next...

Zai Lab Stock Gains 8% Over Clinical Trial Collaboration With Amgen

(RTTNews) - Shares of Zai Lab Limited (ZLAB) are moving up about 8 percent on Wednesday morning trading after the company announced a global clinical trial collaboration with Amgen Inc. (AMGN) to...

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced a global clinical trial collaboration with Amgen Inc. (NASDAQ: AMGN) to evaluate Zai Labs investigational delta-like ligand 3...

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Sees Large Growth in Short Interest

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) saw a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 4,890,948 shares, an increase of 28.7% from the February 26th total of 3,800,411 shares. Based on an average daily...

Zai Lab (NASDAQ:ZLAB) Director Buys $32,733.21 in Stock

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) Director Richard Gaynor bought 1,731 shares of Zai Lab stock in a transaction dated Tuesday, March 17th. The shares were bought at an average cost of $18.91 per share, for a total transaction of $32,733.21. Following the completion of...

Richard Gaynor Acquires 1,731 Shares of Zai Lab (NASDAQ:ZLAB) Stock

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) Director Richard Gaynor acquired 1,731 shares of the business's stock in a transaction that occurred on Tuesday, March 17th. The shares were purchased at an average price of $18.91 per share, with a total value of $32,733.21. Following...

Zai Lab (NASDAQ:ZLAB) Given New $32.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. cut their price target on shares of Zai Lab from $39.00 to $32.00 and set an "overweight" rating for the company in a research note on Wednesday...

Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced three of the Companys internally-developed investigational oncology therapies will be presented across four poster sessions at the upcoming...

Zai Lab (NASDAQ:ZLAB) Insider Rafael Amado Sells 2,957 Shares

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) insider Rafael Amado sold 2,957 shares of the stock in a transaction dated Friday, March 13th. The stock was sold at an average price...

Zai Lab (NASDAQ:ZLAB) CFO Sells $31,726.89 in Stock

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) CFO Yajing Chen sold 1,703 shares of Zai Lab stock in a transaction dated Friday, March 13th. The stock was sold at an average price of...

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Zai Lab Limited - ADR

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

ZLAB
Zai Lab Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZLAB News

ZLABZai Lab Ltd